FTC sues major pharmacy advantage managers around insulin price ranges The agency brought motion from Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the checklist price of life-preserving insulin medicine. Do not skip tomorrow's healthcare business news Let Healthcare Dive's free newsletter continue https://kethek.com/